Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries C4 Therapeutics, Inc. - Common Stock (NQ: CCCC ) 5.850 -0.010 (-0.17%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about C4 Therapeutics, Inc. - Common Stock < Previous 1 2 3 4 5 Next > C4 Therapeutics Announces European Society for Medical Oncology (ESMO) Changed the Previously Accepted CFT1946 Preliminary Phase 1 Abstract to a Proffered Paper Presentation August 14, 2024 Investor Webcast Moved to Friday, September 13, 2024 From C4 Therapeutics, Inc. Via GlobeNewswire CCCC Stock Earnings: C4 Therapeutics Beats EPS, Beats Revenue for Q2 2024 August 01, 2024 CCCC stock results show that C4 Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace C4 Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights August 01, 2024 From C4 Therapeutics, Inc. Via GlobeNewswire C4 Therapeutics to Present Preliminary Monotherapy Data from the Ongoing Phase 1 Trial of CFT1946 as a Mini Oral Presentation at the ESMO Congress 2024 July 16, 2024 From C4 Therapeutics, Inc. Via GlobeNewswire Key Takeaways From C4 Therapeutics Analyst Ratings May 09, 2024 Via Benzinga C4 Therapeutics to Participate in the Virtual UBS Targeted Protein Degradation Day July 08, 2024 From C4 Therapeutics, Inc. Via GlobeNewswire C4 Therapeutics Appoints Ron Cooper as Chairman of the Board of Directors June 10, 2024 From C4 Therapeutics, Inc. Via GlobeNewswire CCCC Stock Earnings: C4 Therapeutics Misses EPS, Misses Revenue for Q1 2024 May 08, 2024 CCCC stock results show that C4 Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights May 08, 2024 From C4 Therapeutics, Inc. Via GlobeNewswire Breaking Down C4 Therapeutics: 4 Analysts Share Their Views February 26, 2024 Via Benzinga Analyst Expectations For C4 Therapeutics's Future January 29, 2024 Via Benzinga C4 Therapeutics Inc. (NASDAQ: CCCC) Leading the Way in Wednesday Trading Based on Percentage Gain January 10, 2024 Via Investor Brand Network C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) April 29, 2024 From C4 Therapeutics, Inc. Via GlobeNewswire C4 Therapeutics to Participate in the Stifel 2024 Targeted Oncology Forum April 09, 2024 From C4 Therapeutics, Inc. Via GlobeNewswire C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor Standard of Care Combinations at the American Association for Cancer Research Annual Meeting 2024 April 08, 2024 From C4 Therapeutics, Inc. Via GlobeNewswire C4 Therapeutics to Present New Preclinical Data on Highly Selective Orally Bioavailable BiDAC™ Degraders at the American Association for Cancer Research Annual Meeting 2024 March 05, 2024 CFT1946 Data Demonstrates Promising Single Agent and Combination Activity in Preclinical Models of BRAF V600X Melanoma, Colorectal Cancer, Non-Small Cell Lung Cancer and Brain Metastasis From C4 Therapeutics, Inc. Via GlobeNewswire C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteins March 04, 2024 From C4 Therapeutics, Inc. Via GlobeNewswire C4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights February 22, 2024 From C4 Therapeutics, Inc. Via GlobeNewswire Capital One Financial To Acquire Discover, Joins SSR Mining And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session February 20, 2024 U.S. stock futures were lower this morning, with the Dow futures trading lower by around 50 points on Tuesday. Via Benzinga Topics Stocks Exposures US Equities 7 Exciting Stocks Poised for Explosive Growth in Key Sectors January 22, 2024 These stocks to buy for growth already have a strong growth story. If they reach their potential investors could see some dynamic returns. Via InvestorPlace C4 Therapeutics Announces 2024 Priorities and Extended Cash Runway to Advance Portfolio of Targeted Protein Degradation Medicines January 09, 2024 From C4 Therapeutics, Inc. Via GlobeNewswire C4 Therapeutics Announces Closing of $25 Million Equity Investment by Betta Pharmaceuticals January 04, 2024 From C4 Therapeutics, Inc. Via GlobeNewswire C4 Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 04, 2024 From C4 Therapeutics, Inc. Via GlobeNewswire MarketBeat Week in Review – 12/18 - 12/22 December 23, 2023 The torrid stock market rally cooled down a little bit heading into the extended holiday weekend; we wish you a Happy Holiday season with friends and family Via MarketBeat Topics Economy Exposures Interest Rates C4 Therapeutics blasts off: what's next? December 18, 2023 As the market soars to new heights, C4 Therapeutics (NASDAQ: CCCC) has become the latest small-cap stock to explode higher in price and volume. Via MarketBeat Topics ETFs C4 Therapeutics Inc. (NASDAQ: CCCC) Near Top of Volume Charts in Friday Trading December 15, 2023 Via Investor Brand Network What's Going On With C4 Therapeutics Stock? December 15, 2023 C4 Therapeutics, Inc. (NASDAQ: CCCC) shares are trading higher Friday, and the stock has gained more than 350% over the past five days. Via Benzinga Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet December 15, 2023 A look at five stocks that saw increased interest from Benzinga readers during the week. Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session December 15, 2023 Via Benzinga C4 Therapeutics Inc. (NASDAQ: CCCC) is One of Thursday Morning’s Most Active Stocks December 14, 2023 Via Investor Brand Network < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.